Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 1998 May 23;316(7144):1559-63.
doi: 10.1136/bmj.316.7144.1559.

Systematic review of efficacy of cognitive behaviour therapies in childhood and adolescent depressive disorder

Affiliations
Meta-Analysis

Systematic review of efficacy of cognitive behaviour therapies in childhood and adolescent depressive disorder

R Harrington et al. BMJ. .

Abstract

Objective: To determine whether cognitive behaviour therapy is an effective treatment for childhood and adolescent depressive disorder.

Design: Systematic review of six randomised trials comparing the efficacy of cognitive behaviour therapy with inactive interventions in subjects aged 8 to 19 years with depressive disorder.

Main outcome measure: Remission from depressive disorder.

Results: The rate of remission from depressive disorder was higher in the therapy group (129/208; 62%) than in the comparison group (61/168; 36%). The pooled odds ratio was 3.2 (95% confidence interval 1.9 to 5.2), suggesting a significant benefit of active treatment. Most studies, however, were based on relatively mild cases of depression and were of only moderate quality.

Conclusions: Cognitive behaviour therapy may be of benefit for depressive disorder of moderate severity in children and adolescents. It cannot, however, yet be recommended for severe depression. Definitive large trials will be required to determine whether the results of this systematic review are reliable.

PubMed Disclaimer

Figures

Figure
Figure
Efficacy of cognitive behavioural therapy in childhood and adolescent depressive disorder. Cochrane odds ratio plot (random effects model)

Comment in

  • Depression in children.
    Hazell P. Hazell P. BMJ. 2002 Aug 3;325(7358):229-30. doi: 10.1136/bmj.325.7358.229. BMJ. 2002. PMID: 12153903 Free PMC article. No abstract available.

Similar articles

Cited by

References

    1. Kolvin I, Barrett ML, Bhate SR, Berney TP, Famuyiwa OO, Fundudis T, et al. The Newcastle child depression project: diagnosis and classification of depression. Br J Psychiatry. 1991;159 (suppl 11):9–21. - PubMed
    1. Harrington RC. Affective disorders. In: Rutter M, Taylor E, Hersov L, editors. Child and adolescent psychiatry: modern approaches. 3rd ed. Oxford: Blackwell Scientific; 1994. pp. 330–350.
    1. Hazell P, O’Connell D, Heathcote D, Robertson J, Henry D. Efficacy of tricyclic drugs in treating child and adolescent depression: a meta-analysis. BMJ. 1995;310:897–901. - PMC - PubMed
    1. Emslie G, Rush A, Weinberg W, Kowatch R, Hughes C, Carmody T, et al. A double-blind, randomized placebo-controlled trial of fluoxetine in depressed children and adolescents. Arch Gen Psychiatry. 1997;54:1031–1037. - PubMed
    1. Simeon JG, Dinicola VF, Ferguson HB, Copping W. Adolescent depression: a placebo-controlled fluoxetine treatment study and follow-up. Prog Neuro-Psychopharm Biol Psychiatry. 1990;14:791–795. - PubMed

Publication types